{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:43:31Z","timestamp":1792017811335,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grants from National Natural Science Foundation of China","award":["82173426"],"award-info":[{"award-number":["82173426"]}]},{"name":"Grants from National Natural Science Foundation of China","award":["82173426"],"award-info":[{"award-number":["82173426"]}]},{"name":"Grants from National Natural Science Foundation of China","award":["82173426"],"award-info":[{"award-number":["82173426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02972-8","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:02:49Z","timestamp":1716562969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients"],"prefix":"10.1007","volume":"316","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-hong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"issue":"10281","key":"2972_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J (2021) Psoriasis. Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/s0140-6736(20)32549-6","journal-title":"Lancet"},{"issue":"4","key":"2972_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol 182(4):840\u2013848. https:\/\/doi.org\/10.1111\/bjd.18245","journal-title":"Br J Dermatol"},{"issue":"19","key":"2972_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"2972_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","author":"A Buonacera","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L (2022) Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2972_CR5","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel FA (2020) Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol 92(10):1733\u20131734. https:\/\/doi.org\/10.1002\/jmv.25819","journal-title":"J Med Virol"},{"issue":"12","key":"2972_CR6","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1002\/jcp.27028","volume":"233","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, Gotto AM Jr, Ruscica M et al (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233(12):9237\u20139246. https:\/\/doi.org\/10.1002\/jcp.27028","journal-title":"J Cell Physiol"},{"key":"2972_CR7","doi-asserted-by":"publisher","first-page":"933913","DOI":"10.3389\/fcvm.2022.933913","volume":"9","author":"Z Ye","year":"2022","unstructured":"Ye Z, Hu T, Wang J et al (2022) Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis. Front Cardiovasc Med 9:933913. https:\/\/doi.org\/10.3389\/fcvm.2022.933913","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"2972_CR8","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1111\/jdv.18860","volume":"37","author":"A Kvist-Hansen","year":"2023","unstructured":"Kvist-Hansen A, Kaiser H, Krakauer M et al (2023) Neutrophil-to-lymphocyte ratio and the systemic immune-inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis. J Eur Acad Dermatol Venereol 37(5):e586\u2013e589. https:\/\/doi.org\/10.1111\/jdv.18860","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2972_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","volume":"18","author":"MA Cupp","year":"2020","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ (2020) Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med 18(1):360. https:\/\/doi.org\/10.1186\/s12916-020-01817-1","journal-title":"BMC Med"},{"issue":"3","key":"2972_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","volume":"43","author":"DS Kim","year":"2016","unstructured":"Kim DS, Shin D, Lee MS et al (2016) Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol 43(3):305\u2013310. https:\/\/doi.org\/10.1111\/1346-8138.13061","journal-title":"J Dermatol"},{"issue":"10","key":"2972_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/1346-8138.13875","volume":"44","author":"A Asahina","year":"2017","unstructured":"Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H (2017) Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. J Dermatol 44(10):1112\u20131121. https:\/\/doi.org\/10.1111\/1346-8138.13875","journal-title":"J Dermatol"},{"issue":"1","key":"2972_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-018-0538-x","volume":"19","author":"P Paliogiannis","year":"2019","unstructured":"Paliogiannis P, Satta R, Deligia G et al (2019) Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med 19(1):37\u201345. https:\/\/doi.org\/10.1007\/s10238-018-0538-x","journal-title":"Clin Exp Med"},{"issue":"5","key":"2972_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.abd.2020.02.008","volume":"95","author":"MC Sirin","year":"2020","unstructured":"Sirin MC, Korkmaz S, Erturan I et al (2020) Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol 95(5):575\u2013582. https:\/\/doi.org\/10.1016\/j.abd.2020.02.008","journal-title":"An Bras Dermatol"},{"issue":"5","key":"2972_CR14","doi-asserted-by":"publisher","first-page":"adv00462","DOI":"10.2340\/00015555-3814","volume":"101","author":"JHO Hoffmann","year":"2021","unstructured":"Hoffmann JHO, Knoop C, Sch\u00e4kel K, Enk AH, Hadaschik EN (2021) Evaluation of psoriasis area and severity index as a proxy for bio-markers of systemic disease under treatment with tumour necrosis factor-alpha and interleukin 12\/23 antagonists in patients with psoriasis: a retrospective cohort study of 186 treatment cycles. Acta Derm Venereol 101(5):adv00462. https:\/\/doi.org\/10.2340\/00015555-3814","journal-title":"Acta Derm Venereol"},{"key":"2972_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12083046","author":"E Sugimoto","year":"2023","unstructured":"Sugimoto E, Matsuda H, Shibata S et al (2023) Impact of pretreatment systemic inflammatory markers on treatment persistence with biologics and conventional systemic therapy: a retrospective study of patients with psoriasis vulgaris and psoriatic arthritis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12083046","journal-title":"J Clin Med"},{"issue":"6","key":"2972_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.29271\/jcpsp.2022.06.773","volume":"32","author":"AB Kelesoglu Dincer","year":"2022","unstructured":"Kelesoglu Dincer AB, Sezer S (2022) Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis. J Coll Physicians Surg Pak 32(6):773\u2013778. https:\/\/doi.org\/10.29271\/jcpsp.2022.06.773","journal-title":"J Coll Physicians Surg Pak"},{"key":"2972_CR17","doi-asserted-by":"publisher","first-page":"1043380","DOI":"10.3389\/fimmu.2023.1043380","volume":"14","author":"G Zhou","year":"2023","unstructured":"Zhou G, Ren X, Tang Z et al (2023) Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data. Front Immunol 14:1043380. https:\/\/doi.org\/10.3389\/fimmu.2023.1043380","journal-title":"Front Immunol"},{"key":"2972_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031840","author":"J Czerwi\u0144ska","year":"2022","unstructured":"Czerwi\u0144ska J, Owczarczyk-Saczonek A (2022) The role of the neutrophilic network in the pathogenesis of psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031840","journal-title":"Int J Mol Sci"},{"key":"2972_CR19","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","volume":"10","author":"CC Chiang","year":"2019","unstructured":"Chiang CC, Cheng WJ, Korinek M, Lin CY, Hwang TL (2019) Neutrophils in psoriasis. Front Immunol 10:2376. https:\/\/doi.org\/10.3389\/fimmu.2019.02376","journal-title":"Front Immunol"},{"issue":"4","key":"2972_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1159\/000520163","volume":"238","author":"JHO Hoffmann","year":"2022","unstructured":"Hoffmann JHO, Enk AH (2022) Evaluation of psoriasis area and severity index thresholds as proxies for systemic inflammation on an individual patient level. Dermatology 238(4):609\u2013614. https:\/\/doi.org\/10.1159\/000520163","journal-title":"Dermatology"},{"issue":"6","key":"2972_CR21","doi-asserted-by":"publisher","first-page":"e14101","DOI":"10.1111\/ijcp.14101","volume":"75","author":"D Dincer Rota","year":"2021","unstructured":"Dincer Rota D, Tanacan E (2021) The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis. Int J Clin Pract 75(6):e14101. https:\/\/doi.org\/10.1111\/ijcp.14101","journal-title":"Int J Clin Pract"},{"key":"2972_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030974","author":"T Hagino","year":"2023","unstructured":"Hagino T, Saeki H, Kanda N (2023) Biomarkers and predictive factors for treatment response to tumor necrosis factor-\u03b1 inhibitors in patients with psoriasis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12030974","journal-title":"J Clin Med"},{"issue":"10","key":"2972_CR23","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.271","volume":"101","author":"JHO Hoffmann","year":"2021","unstructured":"Hoffmann JHO, Knoop C, Enk A, Hadaschik EN (2021) Detailed long-term dynamics of neutrophil-to-lymphocyte ratio under biologic treatment reveals differential effects of tumour necrosis factor-alpha and interleukin 12\/23 antagonists. Acta Derm Venereol 101(10):adv00568. https:\/\/doi.org\/10.2340\/actadv.v101.271","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"2972_CR24","doi-asserted-by":"publisher","first-page":"e13457","DOI":"10.1111\/dth.13457","volume":"33","author":"N Najar Nobari","year":"2020","unstructured":"Najar Nobari N, Shahidi Dadras M, Nasiri S, Abdollahimajd F, Gheisari M (2020) Neutrophil\/platelet to lymphocyte ratio in monitoring of response to TNF-\u03b1 inhibitors in psoriatic patients. Dermatol Ther 33(4):e13457. https:\/\/doi.org\/10.1111\/dth.13457","journal-title":"Dermatol Ther"},{"issue":"2","key":"2972_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/bjd.12663","volume":"170","author":"J Schmitt","year":"2014","unstructured":"Schmitt J, Rosumeck S, Thomaschewski G, Sporbeck B, Haufe E, Nast A (2014) Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol 170(2):274\u2013303. https:\/\/doi.org\/10.1111\/bjd.12663","journal-title":"Br J Dermatol"},{"issue":"11","key":"2972_CR26","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1111\/jdv.14334","volume":"31","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wiles C, Martinez LR, Han G (2017) Neutrophil-to-lymphocyte ratio decreases after treatment of psoriasis with therapeutic antibodies. J Eur Acad Dermatol Venereol 31(11):e491\u2013e492. https:\/\/doi.org\/10.1111\/jdv.14334","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02972-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:31:05Z","timestamp":1719401465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02972-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2972"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02972-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Xiangya Hospital, Central South University, China (protocol number 202308636).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Patient consent was waived due to retrospective design of the study and was approved by the Institutional Review Board of Xiangya Hospital, Central South University, China<b>.<\/b>","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"229"}}